Best Biotech Stocks in India

What Are Biotech Stocks?

Biotech stocks are shares of companies engaged in the biotechnology industry. These companies are involved in the bio innovation and biomanufacturing of products in the fields of healthcare, pharmaceuticals, food production, fuel production, agriculture, and many other fields. The Indian biotech sector is a sunrise industry.

Investing in biotech stocks can offer significant growth and profit potential, as these companies are often at the forefront of scientific advancements and breakthrough treatments. But these stocks also carry higher risks due to the uncertainties associated with clinical trials, regulatory approvals, and market competition. Keeping the caveat in mind, let’s look at the best biotech stocks in India.

What Do Biotech Companies Do?

Biotech companies are involved in scientific discoveries and developing technologies in the field of biotechnology. These companies focus on harnessing biological processes to create innovative products in the fields of medicine, healthcare, etc. The services of these companies are directed at:

1. Research and development (R&D): It is a critical part of biotech, directed toward exploring new areas of biology. Using scientific expertise, these companies solve complex problems and discover new drugs, therapies, diagnostics, and agricultural solutions.
2. Drug discovery and development: These companies focus on discovering new drugs – identifying targets for treating diseases, designing and synthesising drug molecules, and conducting trials to assess the safety and efficacy of the solution.
3. Genetic Engineering and Biomanufacturing: Biotech companies use genetic engineering to modify various organisms to develop therapeutic proteins, enzymes, vaccines, and agricultural products.
4. Agricultural Biotechnology: Biotechnology plays a significant role in enhancing crop yield, improving disease resistance in crops, and enhancing the environmental stress tolerance of plants. They use studies of genetic engineering, breeding techniques, etc. to address these issues.

Indian Biotech Industry: An Overview

India is one of the most prominent destinations for biotech research, and it is one of the reasons to explore Indian biotech stocks. Here are some of the highlights of the Indian biotech sector that will help you form an overall idea before you target biotech stocks:

• In 2022, the Indian biotech industry had crossed US$80.12 billion, growing by 14% from the previous year.
• The sector aims to reach US$ 150 billion by 2025 and US$ 300 billion by 2030.
• India is one of the world’s largest suppliers of low-cost drugs, exporting medicine to 150+ countries.
• At present, India is the 7th largest destination worldwide for conducting affordable clinical trials. 

The Best Biotech Stocks in India

Data as of 5 June, 2023. The stocks are listed according to their market capitalisation. 

Dr. Reddy

By market capitalisation, Dr. Reddy is the largest biotech company in India. The company’s business segments include Global Generics, which engages in the manufacturing and marketing of prescription and over-the-counter drugs. It produces over 190 medicines and 60 active pharmaceutical ingredients (APIs) for global pharmaceutical brands. 

The company caters to the global market. 80% of the company’s revenue comes from outside of India.

Syngene International

The India-based biotech company is engaged in the early discovery, development, and commercial manufacturing of large molecules. It is an integrated research, development, and manufacturing services company for pharmaceuticals, biotechnology, nutrition, animal health, consumer goods, and specialty chemicals.

Biocon

Biocon focuses on developing novel drugs to treat diabetes, oncology, and immunology. The company’s business segments include generics, biosimilars, novel biologics, and research services. It is involved in improving lives in 120 countries.

Sun Pharma Advanced Research

Sun Pharma is the fourth largest generic pharmaceutical company, with a global revenue of US$5.1 billion. The company is involved in the research and development of pharmaceutical products to meet the unmet demands for treatments in the areas of oncology, neurodegeneration, and immunology. It has 40 high-tech manufacturing facilities, and a client base spread across 100 countries.

Wockhardt Ltd

The company’s business includes the manufacturing and marketing of pharmaceutical and bio-pharmaceutical formulations. It produces medicines in the therapeutic areas of dermatology, cosmeceuticals, oncology, medical nutrition, osteoarthritis, and many more. Its comprehensive biotechnology capabilities include – gene cloning, development of production strains, purification, downstream processing and development, testing, market formulation, etc.

Conclusion 

Investing in biotech stocks can help you improve your profit potential. However, these stocks are also considered high risk because of the inherent risks of the business. If you want to explore more investment opportunities, open a Demat account with Angel One and invest in a wide range of asset classes.

Disclaimer: This article has been written for educational purposes only. The securities quoted are only examples and not recommendations.